Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision label 'Revision: v3.3.2' appears on the page. This seems to be a software/version update with no impact on study data or user workflows.SummaryDifference0.1%

- Check21 days agoChange DetectedThe record history shows a new revision entry (v3.3.1) added and an older revision (v3.2.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedA government funding status notice/banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check43 days agoChange DetectedThe update is a minor change to the record history presentation and does not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.